Chemo Pharma Laboratories Share Price
₹95.00 +1.5 (1.6%)
20 Jan, 2025 06:45
Start SIP in CHEMOPH
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month -7.51%
- Over 3 Month + 34.92%
- Over 6 Month + 50.79%
- Over 1 Year + 27.12%
Smart Investing Starts Here Start SIP with Chemo Pharma Laboratories for Steady Growth!
Chemo Pharma Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Chemo Pharma Laboratories Financials
Chemo Pharma Laboratories Technicals
EMA & SMA
Current Price
₹95.00
+
1.5
(1.6%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹99.35
- 50 Day
- ₹95.57
- 100 Day
- ₹87.90
- 200 Day
- ₹78.56
Resistance and Support
93.45
- R3 105.70
- R2 101.10
- R1 98.05
- S1 90.40
- S2 85.80
- S3 82.75
Chemo Pharma Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-27 | Quarterly Results | |
2024-10-28 | Quarterly Results | |
2024-07-29 | Quarterly Results & A.G.M. | |
2024-05-27 | Audited Results | |
2024-01-29 | Quarterly Results & Others | Inter alia, to consider and approve the Re-Appointment of M/s Kavita Khatri & Associates Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2023-24. |
Chemo Pharma Laboratories F&O
About Chemo Pharma Laboratories
- NSE Symbol
- CHEMOPH
- BSE Symbol
- 506365
- ISIN
- INE320M01019
Similar Stocks to Chemo Pharma Laboratories
Chemo Pharma Laboratories FAQs
Chemo Pharma Laboratories share price is ₹95 As on 20 January, 2025 | 06:31
The Market Cap of Chemo Pharma Laboratories is ₹14.2 Cr As on 20 January, 2025 | 06:31
The P/E ratio of Chemo Pharma Laboratories is 11.5 As on 20 January, 2025 | 06:31
The PB ratio of Chemo Pharma Laboratories is 1.1 As on 20 January, 2025 | 06:31
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.